Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree

Background and objective Due in part to remarkable advances over the past decade in our understanding of lung cancer, there is a pressing need for a revised classification. The aim of this study was to explore and verify the clinical significance of a new molecular classification of non-small cell l...

Full description

Bibliographic Details
Main Authors: Nana WANG, Nan JIANG, Xiaoqing YANG, Lei FANG, Qing SUN
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2018-07-01
Series:Chinese Journal of Lung Cancer
Subjects:
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.05
_version_ 1828427749286477824
author Nana WANG
Nan JIANG
Xiaoqing YANG
Lei FANG
Qing SUN
author_facet Nana WANG
Nan JIANG
Xiaoqing YANG
Lei FANG
Qing SUN
author_sort Nana WANG
collection DOAJ
description Background and objective Due in part to remarkable advances over the past decade in our understanding of lung cancer, there is a pressing need for a revised classification. The aim of this study was to explore and verify the clinical significance of a new molecular classification of non-small cell lung cancer (NSCLC) on the basis of anatomic site of bronchial tree. Methods Double-immunohistochemistry were performed in 105 tumor samples paring with normal lung tissue from non-small cell lung cancer patients by using monoclonal antibody of P63/NapsinA and TTF-1/CK7. By comprehensively analyzing the express profiles of tumors and normal lung tissues, histological characteristics we proposed a brand new pathological classification based on histogenesis for NSCLC and divided them as: bronchiole epithelial cell carcinoma, bronchiole-alveolar cell carcinoma, alveolar cell carcinoma and secretory adenocarcinoma. And to analyze the relationship between this classification and epidermal growth factor receptor (EGFR) mutation and ognosis. Results Further investigation revealed that our new classification showed strong relevancy with EGFR mutations and effective indicators for prognosis. Conclusion The classification system for NSCLC proposed by our research group is convenient for pathological diagnosis and valuable in clinical application.
first_indexed 2024-12-10T17:08:19Z
format Article
id doaj.art-3ab9cdcde94c46d79ced766e8c6bc9bc
institution Directory Open Access Journal
issn 1009-3419
1999-6187
language zho
last_indexed 2024-12-10T17:08:19Z
publishDate 2018-07-01
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
record_format Article
series Chinese Journal of Lung Cancer
spelling doaj.art-3ab9cdcde94c46d79ced766e8c6bc9bc2022-12-22T01:40:24ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872018-07-0121753053510.3779/j.issn.1009-3419.2018.07.05Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial TreeNana WANG0Nan JIANG1Xiaoqing YANG2Lei FANG3Qing SUN4Department of Pathology, Qianfoshan Hospit al Affiliated to Shandong University, Jinan 250000, ChinaDepartment of Pathology, Shandong Provincial Hospital West Hospital, Jinan 250022, ChinaDepartment of Pathology, Qianfoshan Hospit al Affiliated to Shandong University, Jinan 250000, ChinaDepartment of Pathology, Qianfoshan Hospit al Affiliated to Shandong University, Jinan 250000, ChinaDepartment of Pathology, Qianfoshan Hospit al Affiliated to Shandong University, Jinan 250000, ChinaBackground and objective Due in part to remarkable advances over the past decade in our understanding of lung cancer, there is a pressing need for a revised classification. The aim of this study was to explore and verify the clinical significance of a new molecular classification of non-small cell lung cancer (NSCLC) on the basis of anatomic site of bronchial tree. Methods Double-immunohistochemistry were performed in 105 tumor samples paring with normal lung tissue from non-small cell lung cancer patients by using monoclonal antibody of P63/NapsinA and TTF-1/CK7. By comprehensively analyzing the express profiles of tumors and normal lung tissues, histological characteristics we proposed a brand new pathological classification based on histogenesis for NSCLC and divided them as: bronchiole epithelial cell carcinoma, bronchiole-alveolar cell carcinoma, alveolar cell carcinoma and secretory adenocarcinoma. And to analyze the relationship between this classification and epidermal growth factor receptor (EGFR) mutation and ognosis. Results Further investigation revealed that our new classification showed strong relevancy with EGFR mutations and effective indicators for prognosis. Conclusion The classification system for NSCLC proposed by our research group is convenient for pathological diagnosis and valuable in clinical application.http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.05Lung neoplasmsHistogenesisPathological classificationEGFR
spellingShingle Nana WANG
Nan JIANG
Xiaoqing YANG
Lei FANG
Qing SUN
Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
Chinese Journal of Lung Cancer
Lung neoplasms
Histogenesis
Pathological classification
EGFR
title Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
title_full Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
title_fullStr Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
title_full_unstemmed Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
title_short Clinical Evaluation of A New Pathological Classification for 
Non-small Cell Lung Cancer Based on Histogenesis of Bronchial Tree
title_sort clinical evaluation of a new pathological classification for 
non small cell lung cancer based on histogenesis of bronchial tree
topic Lung neoplasms
Histogenesis
Pathological classification
EGFR
url http://dx.doi.org/10.3779/j.issn.1009-3419.2018.07.05
work_keys_str_mv AT nanawang clinicalevaluationofanewpathologicalclassificationfornonsmallcelllungcancerbasedonhistogenesisofbronchialtree
AT nanjiang clinicalevaluationofanewpathologicalclassificationfornonsmallcelllungcancerbasedonhistogenesisofbronchialtree
AT xiaoqingyang clinicalevaluationofanewpathologicalclassificationfornonsmallcelllungcancerbasedonhistogenesisofbronchialtree
AT leifang clinicalevaluationofanewpathologicalclassificationfornonsmallcelllungcancerbasedonhistogenesisofbronchialtree
AT qingsun clinicalevaluationofanewpathologicalclassificationfornonsmallcelllungcancerbasedonhistogenesisofbronchialtree